fda compounding semaglutide enforcement 2025 news Patients struggle as compounded GLP-1 access rapidly shrinks Novo Nordisk expands legal action

These types of medications can help manage blood sugar levels, however early research is showing GLP-1 and anesthesia can create adverse complications for the patient

In a large RCT involving obese and prediabetic individuals, tirzepatide significantly delayed the onset of T2DM compared with placebo across multiple doses, with sustained benefits observed during long-term follow-up

Unusual odor from the vial suggests bacterial contamination or significant chemical breakdown

Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primates

In the OASIS 4 trial, people taking the once-daily tablet at 25 mg lost 16.6% of their starting body weight over 64 weeks (1 year, 3 months) when they stuck to the treatment and followed healthy lifestyle guidance